TX HHS Form 1329. Kidney Health Care Program Drug Rebate Agreement

The Texas Health and Human Services (HHS) Kidney Health Care Program Drug Rebate Agreement (Form 1329) is a crucial document for manufacturers of covered outpatient drugs. This agreement outlines the responsibilities of both HHS and the manufacturer in providing adequate kidney care and treatment to citizens of Texas.

This form is intended for use by pharmaceutical companies that wish to have their products included on the KHC formulary. The manufacturer must agree to provide pricing data, make rebate payments within a specified timeframe, and comply with all applicable state and federal laws and regulations. The agreement also defines key terms, including Average Manufacturer Price, Best Price, and Unit Rebate Amount.

The purpose of this document is to facilitate the reimbursement process for covered outpatient drugs purchased by or on behalf of KHC clients. By understanding the requirements outlined in this agreement, manufacturers can ensure compliance with federal regulations and maintain a strong partnership with HHS. This document is essential for any manufacturer seeking to participate in the Texas Kidney Health Care Program.